Patients with a G3 tumor, who died in the follow-up period, showed considerably increased IL-15 values, in contrast to the significantly decreased IL-15 levels in patients with G3 tumor with favourable OS and DFS and were living at follow-up. The gene discussed is IL15; the disease is neoplasm.